AAAAAA
Results: 1-25/33
Authors:
Fennerty, MB
Magaret, N
Dalros, L
Faigel, D
Lieberman, D
Shaw, M
Citation: Mb. Fennerty et al., Outcomes of Helicobacter pylori treatment in community practice and impactof therapeutic effectiveness information on physician behaviour, ALIM PHARM, 15(9), 2001, pp. 1453-1458
Authors:
Magaret, N
Burm, M
Faigel, D
Kelly, C
Peterson, W
Fennerty, MB
Citation: N. Magaret et al., A randomized trial of lansoprazole, amoxycillin, and clarithromycin versuslansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy, DIGEST DIS, 19(2), 2001, pp. 174-178
Authors:
Morales, TG
Sampliner, RE
Camargo, E
Marquis, S
Garewal, HS
Fennerty, MB
Citation: Tg. Morales et al., Inability to noninvasively diagnose gastric intestinal metaplasia in hispanics or reverse the lesion with Helicobacter pylori eradication, J CLIN GAST, 32(5), 2001, pp. 400-404
Authors:
Fennerty, MB
Citation: Mb. Fennerty, Acid peptic disease - A four-article symposium, POSTGR MED, 110(3), 2001, pp. 41-41
Authors:
Fennerty, MB
Citation: Mb. Fennerty, NSAID-related gastrointestinal injury - Evidence-based approach to a preventable complication, POSTGR MED, 110(3), 2001, pp. 87
Authors:
Fennerty, MB
Corless, CL
Sheppard, B
Faigel, DO
Lieberman, DA
Sampliner, RE
Citation: Mb. Fennerty et al., Pathological documentation of complete elimination of Barrett's metaplasiafollowing endoscopic multipolar electrocoagulation therapy, GUT, 49(1), 2001, pp. 142-144
Authors:
Freeman, ML
DiSario, JA
Nelson, DB
Fennerty, MB
Lee, JG
Bjorkman, DJ
Overby, CS
Aas, J
Ryan, ME
Bochna, GS
Shaw, MJ
Snady, HW
Erickson, RV
Moore, JP
Roel, JP
Citation: Ml. Freeman et al., Risk factors for post-ERCP pancreatitis: a prospective, multicenter study, GASTROIN EN, 54(4), 2001, pp. 425-434
Authors:
Sampliner, RE
Faigel, D
Fennerty, MB
Lieberman, D
Ippoliti, A
Lewin, K
Weinstein, WM
Citation: Re. Sampliner et al., Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study, GASTROIN EN, 53(6), 2001, pp. 554-558
Authors:
Laine, L
Schoenfeld, P
Fennerty, MB
Citation: L. Laine et al., Therapy for Helicobacter pylori in patients with nonulcer dyspepsia - A meta-analysis of randomized, controlled trials, ANN INT MED, 134(5), 2001, pp. 361-369
Authors:
Fennerty, MB
Citation: Mb. Fennerty, Strategies for diagnosis and short and long term treatment: Respondent overview, AM J GASTRO, 96(8), 2001, pp. S27-S28
Authors:
Fennerty, MB
Triadafilopoulos, G
Citation: Mb. Fennerty et G. Triadafilopoulos, Barrett's-related esophageal adenocarcinoma: Is chemoprevention a potential option?, AM J GASTRO, 96(8), 2001, pp. 2302-2305
Authors:
Fennerty, MB
Citation: Mb. Fennerty, Ablative therapies for Barrett's esophagus, AM J M CARE, 6(16), 2000, pp. S899-S902
Authors:
Fass, R
Ofman, JJ
Sampliner, RE
Camargo, L
Wendel, C
Fennerty, MB
Citation: R. Fass et al., The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis, ALIM PHARM, 14(4), 2000, pp. 389-396
Authors:
Talley, NJ
Vakil, N
Fennerty, MB
Citation: Nj. Talley et al., Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. Reply, N ENG J MED, 342(8), 2000, pp. 590-590
Authors:
Hahn, M
Fennerty, MB
Corless, CL
Magaret, N
Lieberman, DA
Faigel, DO
Citation: M. Hahn et al., Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection, GASTROIN EN, 52(1), 2000, pp. 20-26
Authors:
Sharma, VK
Corder, FA
Raufman, JP
Sharma, P
Fennerty, MB
Howden, CW
Citation: Vk. Sharma et al., Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance, AM J GASTRO, 95(8), 2000, pp. 2068-2073
Authors:
Laine, L
Fennerty, MB
Osato, M
Sugg, J
Suchower, L
Probst, P
Levine, JG
Citation: L. Laine et al., Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials, AM J GASTRO, 95(12), 2000, pp. 3393-3398
Authors:
Faigel, DO
Magaret, N
Corless, C
Lieberman, DA
Fennerty, MB
Citation: Do. Faigel et al., Evaluation of rapid antibody tests for the diagnosis of Helicobacter pylori infection, AM J GASTRO, 95(1), 2000, pp. 72-77
Authors:
Fennerty, MB
Citation: Mb. Fennerty, Initial management of unexplained dyspepsia without alarm symptoms: Empirical therapy or endoscopy?, ACP KEY DIS, 2000, pp. 27-41
Authors:
Fennerty, MB
Citation: Mb. Fennerty, Extraesophageal gastroesophageal reflux disease - Presentations and approach to treatment, GASTRO CLIN, 28(4), 1999, pp. 861
Authors:
Fennerty, MB
Citation: Mb. Fennerty, Tissue staining (chromoscopy) of the gastrointestinal tract, CAN J GASTR, 13(5), 1999, pp. 423-429
Authors:
Knigge, K
Kelly, C
Peterson, WL
Fennerty, MB
Citation: K. Knigge et al., Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days, ALIM PHARM, 13(3), 1999, pp. 323-326
Authors:
Fass, R
Fennerty, MB
Johnson, C
Camargo, L
Sampliner, RE
Citation: R. Fass et al., Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease, J CLIN GAST, 28(1), 1999, pp. 36-39
Authors:
Talley, NJ
Vakil, N
Ballard, ED
Fennerty, MB
Citation: Nj. Talley et al., Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia, N ENG J MED, 341(15), 1999, pp. 1106-1111
Authors:
Dent, J
Brun, J
Fendrick, AM
Fennerty, MB
Janssens, J
Kahrilas, PJ
Lauritsen, K
Reynolds, JC
Shaw, M
Talley, NJ
Citation: J. Dent et al., An evidence-based appraisal of reflux disease management - the Genval workshop report, GUT, 44, 1999, pp. S1-S16